The Drug Regulatory Authority of Pakistan (DRAP) has confirmed that pharmaceutical companies now have the authority to set prices for half of the medicines available in the country. However, the government still controls the prices of essential medicines.
DRAP CEO Dr. Obaidullah stated in a TV interview that the government’s authority over essential drug prices remains intact, but 50% of medicines have been deregulated, giving companies the power to set their own prices.
He said a survey of 100 medicines has been completed, and the government will act immediately on any instructions it receives. Dr. Obaidullah also announced a second phase to survey the prices of more medicines, especially those that have become more expensive in the market.
The move comes as part of ongoing efforts to monitor and regulate medicine prices in Pakistan, ensuring that essential drugs remain affordable while allowing market forces to determine prices for other medicines.